Compared to Estimates, Chart Industries (GTLS) Q2 Earnings: A Look at Key Metrics

Chart Industries (GTLS) reported Q2 2025 revenue of $1.08 billion and EPS of $2.59, both slightly missing Zacks Consensus Estimates by -3.22% and -1.15% respectively. Despite these headline misses, the company's total backlog reached $5.54 billion, exceeding analyst expectations, driven by strong orders in Specialty Products and Repair, Service & Leasing segments. Heat Transfer Systems sales also demonstrated robust growth, increasing 24.8% year-over-year. GTLS shares have outperformed the S&P 500 over the past month, rising 4.3%.

Analysis

Chart Industries (GTLS) presented a mixed financial picture for its second quarter of 2025, characterized by headline misses but strong underlying forward-looking metrics. The company reported revenue of $1.08 billion and EPS of $2.59, falling short of consensus estimates by 3.22% and 1.15%, respectively. Despite these misses, the figures still represent year-over-year growth, with revenue up 4% and EPS increasing from $2.18 a year prior. The more telling story resides in the company's operational metrics, where the total backlog reached $5.54 billion, significantly exceeding the $5.24 billion analyst estimate. This backlog strength was driven by outperformance in Specialty Products and Repair, Service & Leasing. Similarly, new orders in these segments substantially surpassed expectations, signaling robust future demand. However, current sales performance was uneven across divisions; while Heat Transfer Systems sales grew an impressive 24.8% year-over-year, sales in Cryo Tank Solutions and Repair, Service & Leasing both contracted compared to the previous year and missed estimates. The market appears to be weighing the positive leading indicators more heavily, as the stock's 4.3% gain over the past month has outpaced the S&P 500.

Key Decisions for Investors

• Investors should look past the minor top and bottom-line misses and focus on the strength in forward-looking indicators, as the $5.54 billion backlog beat suggests a strong revenue pipeline.
• Monitor the execution of converting the robust order book, particularly in the Specialty Products segment, into recognized revenue to justify the stock's recent outperformance.
• Given the divergence between strong future bookings and mixed current sales, a neutral stance is warranted until there is clear evidence of broad-based sales acceleration across all key segments.